Wave Life Sciences (WVE) Total Liabilities (2014 - 2026)
Wave Life Sciences posted quarterly Total Liabilities of $71.8 million for Q1 2026, down 33.91% year-on-year from $108.7 million in Q1 2025, and down 36.03% on a QoQ basis from $112.3 million in Q4 2025.
Wave Life Sciences (WVE) has 13 years of Total Liabilities data on file, last reported at $71.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 33.91% year-over-year to $71.8 million; the trailing twelve-month figure through Mar 2026 stood at $71.8 million (down 33.91% YoY), and the FY2025 full-year result was $112.3 million, down 16.73% from the prior year.
- Total Liabilities for Q1 2026 stood at $71.8 million, down from $112.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $294.1 million in Q1 2023 and bottomed at $71.8 million in Q1 2026.
- The 5-year median for Total Liabilities is $178.2 million (2022), against an average of $175.3 million.
- The widest annual swing landed in 2023, when Total Liabilities jumped 84.35%; it then tumbled 48.53% in 2025.
- A 5-year view of Total Liabilities shows it stood at $183.6 million in 2022, then climbed by 23.88% to $227.4 million in 2023, then sank by 40.73% to $134.8 million in 2024, then decreased by 16.73% to $112.3 million in 2025, then tumbled by 36.03% to $71.8 million in 2026.
- The last three Total Liabilities figures came in at $71.8 million (Q1 2026), $112.3 million (Q4 2025), and $109.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 71.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.81 Mn |
| Dec 31, 2025 | 112.27 Mn |
| Sep 30, 2025 | 108.96 Mn |
| Jun 30, 2025 | 105.22 Mn |
| Mar 31, 2025 | 108.67 Mn |
| Dec 31, 2024 | 134.82 Mn |
| Sep 30, 2024 | 208.99 Mn |
| Jun 30, 2024 | 204.42 Mn |
| Mar 31, 2024 | 202.01 Mn |
| Dec 31, 2023 | 227.45 Mn |
| Sep 30, 2023 | 232.53 Mn |
| Jun 30, 2023 | 273.83 Mn |
| Mar 31, 2023 | 294.11 Mn |
| Dec 31, 2022 | 183.60 Mn |
| Sep 30, 2022 | 178.16 Mn |
| Jun 30, 2022 | 174.50 Mn |
| Mar 31, 2022 | 159.54 Mn |
| Dec 31, 2021 | 166.64 Mn |
| Sep 30, 2021 | 162.74 Mn |
| Jun 30, 2021 | 176.70 Mn |
| Mar 31, 2021 | 181.95 Mn |
| Dec 31, 2020 | 188.59 Mn |
| Sep 30, 2020 | 193.95 Mn |
| Jun 30, 2020 | 200.57 Mn |
| Mar 31, 2020 | 209.84 Mn |
| Dec 31, 2019 | 212.64 Mn |
| Sep 30, 2019 | 224.57 Mn |
| Jun 30, 2019 | 217.45 Mn |
| Mar 31, 2019 | 225.88 Mn |
| Dec 31, 2018 | 214.72 Mn |
| Sep 30, 2018 | 210.10 Mn |
| Jun 30, 2018 | 206.57 Mn |
| Mar 31, 2018 | 32.50 Mn |
| Dec 31, 2017 | 34.36 Mn |
| Sep 30, 2017 | 28.36 Mn |
| Jun 30, 2017 | 29.65 Mn |
| Mar 31, 2017 | 26.55 Mn |
| Dec 31, 2016 | 22.07 Mn |
| Sep 30, 2016 | 20.97 Mn |
| Jun 30, 2016 | 16.19 Mn |
| Mar 31, 2016 | 4.13 Mn |
| Dec 31, 2015 | 4.06 Mn |
| Sep 30, 2015 | 3.60 Mn |
| Dec 31, 2014 | 911,000.00 |